*Clinical trials have indicated that medications like Topiramate can lead to weight reductions of up to 10% when administered to individuals with Type-2 Diabetes who consistently maintained a daily dosage of 150 mg, followed a reduced-calorie diet, and engaged in increased physical activity for a duration of 24 weeks.
*Based on patients without diabetes who achieved and sustained a dose of 2.4 mg/week of GLP-1 therapy, combined with a reduced-calorie diet and increased physical activity, in their 68-week clinical studies.
Angie, Juna member for 8 months
Eva, Juna member for 2 months
Remy, Juna member for 4 months
Alex, Juna member for 3 months
Behnaz, Juna member for 4 months